Paediatric Clinical Trials
31ST March – 1ST April 2014
The Kensington Close Hotel, London UK
Sponsored by PPD
Building on the success of our previous events, SMi is proud to present the 8th instalment in the popular conference series; Paediatric Clinical Trials , taking place on 31st March and 1st April 2014, London UK.
This event will bring together key opinion leaders to provide attendees with an in depth look into current advances in paediatric clinical trials and drug development with a complete view of the paediatric market.
Presentations will focus on regulatory requirements, challenges in clinical trials design, formulation development, extrapolation form the adult population plus much more.
Why Attend this Event in 2014:
• Discuss the global paediatric legislations and an impact assessment of the EU legislation
• Learn about PIP submissions
• Discover how the FDA changes the regulatory landscape for paediatric drug development in the US
• Explore how clinical trials are organised in Hungary
• Analyse vaccines trials vs. antibiotic trials
• Evaluate the experience of a paediatrics ethics committee
• Examine extrapolation in paediatric drug development
• Consider formulation development and paediatric psychopharmacology
Key Speakers:
• Bruno Reigner, Senior Clinical Pharmacologist, Roche Pharmaceuticals
• David McIntosh, Global Scientific Affairs Senior Expert, Novartis Vaccines
• Philippe Auby, Director, International Clinical Research, Paediatric Neuro-Psychiatry, Lundbeck
• Christina Bucci-Rechtweg, Head, Maternal & Paediatric Regulatory Policy, Novartis
• Klaus Rose, CEO, Klausrose Consulting
• Elin Haf Davies, Director & Founder, Empowering Children | Enabling Research
• Daniel Bar-Shalom, Associate Professor, University of Copenhagen
• Daniel De Wolf, Director - Department of Paediatric Cardiology, Ghent University Hospital
• Karl-Heinz Huemer, Scientific Office, Austrian Agency for Health and Food Safety
• Otto Skoran, CEO, Svabhegy Paediatric Hospital
• Mark Sorrentino, Executive Medical Director, PPD Consulting
Previous instalments received positive feedback from the industry including, "Good presentations and important topics" – Abbott, "I very much enjoyed this conference, thanks to the organisers" – UCB and "Very good meeting" - Boehringer Ingelheim
